The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to develop a safe and effective SARS-CoV-2 vaccine. However, each vaccine strategy has distinct advantages and disadvantages. Therefore, it is important to evaluate multiple vaccine platforms to select the most efficient vaccine platform for SARS-CoV-2. In this regard, Newcastle disease virus (NDV), an avian virus, has several well-suited properties for development of a vector vaccine against SARS-CoV-2. Here, we elaborate on the idea of considering NDV as a vaccine vector for SARS-CoV-2.
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, coronavirus, Newcastle disease virus (NDV), viral vector and viral respiratory infection, 【초록키워드】 Infection, virus, SARS-CoV-2 vaccine, death, vaccine platform, newcastle disease virus, Disadvantages, Safe, acute respiratory syndrome, effective, develop, evaluate, 【제목키워드】 vector,